Future of Psychiatry! Innovations in Mental Health
Psychedelic Health Insurance Benefits with Sherry Rais
Feb 14, 2024
Sherry Rais, CEO of Anthea, discusses pioneering accessible psychedelic-assisted therapies, starting with ketamine treatment. They explore the transformative potential of these therapies, challenges in integrating psychedelic therapy into insurance policies, and the benefits of offering ketamine therapy as an employee benefit. The podcast also addresses stigma associated with psychedelic therapy, underutilization of mental health benefits post-COVID, and the importance of personalized treatments for better mental health outcomes.
32:50
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ketamine therapy offers transformative mental health treatment by increasing neuroplasticity and resetting the brain.
- Emphea aims to provide safe and accessible psychedelic-assisted therapies like ketamine treatment to alleviate human suffering and expand coverage for MDMA and psilocybin therapies.
Deep dives
The Benefits of Ketamine Therapy
Ketamine therapy, a dissociative experience working on NMDA receptors in the brain, offers a transformative mental health treatment. It increases neuroplasticity, allowing the brain to reset. Employers can provide nationwide coverage of ketamine therapy as an employee benefit, leading to lower medical costs and a more engaged workforce.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
